New Complaint Allowed In AstraZeneca Pain Med Suit

Law360, New York (July 24, 2009, 2:40 PM EDT) -- A district judge has directed the plaintiffs in a suit accusing AstraZeneca LP of making a defective pain medication to file an amended complaint with more specific allegations about the medication, and has denied both parties' requests for costs associated with bringing several purportedly superfluous motions.

In a ruling handed down Wednesday, Judge Karen K. Caldwell of the U.S. District Court for the Eastern District of Kentucky told plaintiffs Rachel and Gary Grigsby to tender an amended complaint and denied both motions for costs, finding that...
To view the full article, register now.